Toxicity of Antifungal Drugs Itraconazole and Fluconazole in Rats by Abdul Rahman, Nor Shahida
  
 
UNIVERSITI PUTRA MALAYSIA 
 
 
TOXICITY OF ANTIFUNGAL DRUGS ITRACONAZOLE AND 
FLUCONAZOLE IN RATS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOR SHAHIDA ABDUL RAHMAN 
 
 
FPSK(M) 2004 8 
TOXICITY OF ANTIFUNGAL DRUGS ITRACONAZOLE AND 
FLUCONAZOLE IN RATS 
BY 
NOR SHAHIDA ABDUL RAHMAN 
Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia in 
Fulfilment of the Requirements for the Degree of Master of Science 
March 2004 
DEDICATION 
"Dedicated especially to my parents Abdul Rahman Mat and Tuan Zaharah Tuan 
Yusoff, sisters, brothers and all those individuals behind the scenes who make ne 
possible to complete my study successfully." 
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment of 
the requirements for the degree of Master of Science 
TOXICITY OF ANTIFUNGAL DRUGS ITRACONAZOLE AND 
FLUCONAZOLE IN RATS 
BY 
NOR SHAHIDA ABDUL RAHMAN 
March 2004 
Chairman: Associate Professor Muhammad Nazrul Hakim Abdullah, Ph.D. 
Faculty: Medicine and Health Sciences 
Itraconazole and Fluconazole are the newer antifungal drugs that have been used for 
several years. Both these drugs have a broad-spectrum antifungal activity and 
currently are used to treat infections caused by Candida albicans, Aspergillus spp., 
Paracoccidioides brasiliensis, Sporothrix schenckii, Histoplasma capsulatum, 
Ciyptococcus neoformans and many others. The objective of this study is to 
investigate the in vitro and in vivo cytotoxicity of these two antifungal drugs. The in 
vitro and in vivo cytotoxicity of fluconazole and itraconazole were studied in thirty 
eight male Sprague Dawley rats. Freshly isolated rat hepatocytes were obtained for the 
in vitro treatment of fluconazole and itraconazole using a liver perfusion technique. 
The cell viability test was done by trypan blue exclusion. As a result, both fluconazole 
and itraconazole cause a reduction in cell viability of hepatocytes. However, 
itraconazole exerted its cytotoxicity more than fluconazole in both time- and dose- 
dependent manner. Meanwhile, cytotoxicity of itraconazole was reduced significantly 
by Phenobarbital pretreatment. Phenobarbital did not have any effect on the 
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cytotoxicity induced by fluconazole. In vivo studies revealed that rat's liver and 
kidney treated with repeated-doses of itraconazole showed a significantly higher in 
total protein in liver and kidney and significant increase in serum ALP and ALT 
activity. This is in agreement with histological findings that the rat treated with 
repeateddoses of itraconazole showed severe histological features compared to 
fluconazole. Morphological changes such as inflammation and fibrosis of liver were 
frequently seen in repeated-doses of itraconazole. This present study suggests that 
Phenobarbital plays a role in the cytoprotection of hepatocytes to itraconazole-induced 
but not fluconazole-induced cytotoxicity in vitro. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
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Itraconazole dan fluconazole tergolong di antara dadah anti-kulat yang baru 
diperkenalkan dan telah digunakan sejak beberapa tahun yang lalu. Kedua-dua dadah 
anti-kulat ini telah digunakan secara meluas terutarnanya dalam merawat jangkitan 
yang disebabkan oleh Candida albicans, Aspergillus spp., Paracoccidioides 
brasiliensis, Sporothrix schenckii, Histoplasma capsulatum, Cryptococcus 
neoformans dan sebagainya. Objektif kajian ini adalah untuk mengetahui ketoksikan 
kedua-dua dadah ini secara in vitro dan in vivo. Di dalam kajian ini tiga puluh lapan 
ekor tikus jantan dari spesies Sprague Dawley telah digunakan. Pengasingan sel 
hepatosit tikus segar dapat dibuat untuk digunakan dalam rawatan in vitro oleh 
fluconazole dan itraconazole dengan menggunakan teknik perhsi hati. Ujian untuk 
menguji sel-sel hidup dibuat menggunakan tripan biru. Fluconazole dan itraconazole 
menyebabkan penurunan kepada bilangan sel hepatosit yang hidup. 
Walaubagaimanapun, itraconazole menunjukkan kesan ketoksikan yang lebih tinggi 
berbanding fluconazole dalam keadaan berkadar langsung dengan masa dan dos. 
Sementara itu, ketoksikan yang disebabkan oleh dadah anti-kulat itraconazole dapat 
dikurangkan dengan menggunakan Phenobarbital. Phenobarbital tidak mempengaruhi 
ketoksikan yang disebabkan oleh fluconazole. Kajian in vivo juga menunjukkan 
terdapat peningkatan dalam jumlah protein dan aktiviti serum ALP dan ALT di dalam 
hati clan buah pinggang tikus yang diberi suntikan itraconazole secara berulang-kali. 
Secara histologinya, tikus yang diberi suntikan itraconazole secara berulang-kali 
menunjukkan kesan ketoksikan yang ketara terhadap hati dan buah pinggang tikus jika 
dibandingkan dengan tikus yang diberi suntikan fluconazole secara berulang-kali. 
Perubahan morfologi seperti keradangan dan fibrosis pada hati telah dilihat dengan 
kerap dalam suntikan itraconazole secara berulang-kali. Dengan itu, kajian ini telah 
menunjukkan bahawa phenobarbital memainkan peranan dalam mengurangkan 
ketoksikan yang dihasilkan oleh itraconazole tetapi tidak mempengaruhi ketoksikan 
yang disebabkan oleh fluconazole secara in vitro. 
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